-transparent.png){kind=logo}
The effects of the new thromboxane A2 (TXA2) synthetase inhibitor sodium 6-(2-[1-(1H)-imidazolyl]methyl-4,5-dihydrobenzo[b]thiophene)carboxylate (RS-5186), 10 mg/kg i.v., on infarct size, polymorphonuclear leukocytes (PMNs) infiltration, gross myocardial hemorrhage and ventricular arrhythmias were studied using a canine coronary occlusion (2 h)-reperfusion (5 h) model. Infarct size (IS) and risk area (RA) were determined by a dual staining technique. 60 min before coronary occlusion dogs were randomly assigned to either the RS-5186 treated group (n = 11) or the control group (n = 15). RS-5186 reduced infarct size (RS-5186: 26.3 +/- 2.4% of RA (mean +/- SEM) vs control: 50.7 +/- 5.9%, p less than 0.01), and also reduced the area of gross myocardial hemorrhage (RS-5186: 3.9 +/- 2.6% of IS vs control: 22.4 +/- 4.0%, p less than 0.01). The drug also decreased the intensity of PMNs infiltration into the infarcted area (p less than 0.05). However, RS-5186 had no significant influence on the incidence of ventricular arrhythmias. These results suggest that the new thromboxane A2 synthetase inhibitor RS-5186 might be useful in salvaging ischemic myocardium.
Y Toki, and
N Hieda, and
K Okumura, and
H Hashimoto, and
T Ito, and
K Ogawa, and
T Satake
January 1990,
Japanese heart journal,
Y Toki, and
N Hieda, and
K Okumura, and
H Hashimoto, and
T Ito, and
K Ogawa, and
T Satake
May 1996,
The Journal of surgical research,
Y Toki, and
N Hieda, and
K Okumura, and
H Hashimoto, and
T Ito, and
K Ogawa, and
T Satake
January 1993,
Archives internationales de pharmacodynamie et de therapie,
Y Toki, and
N Hieda, and
K Okumura, and
H Hashimoto, and
T Ito, and
K Ogawa, and
T Satake
January 1983,
Current surgery,
Y Toki, and
N Hieda, and
K Okumura, and
H Hashimoto, and
T Ito, and
K Ogawa, and
T Satake
May 1996,
Transplantation,
Y Toki, and
N Hieda, and
K Okumura, and
H Hashimoto, and
T Ito, and
K Ogawa, and
T Satake
June 1996,
Japanese circulation journal,
Y Toki, and
N Hieda, and
K Okumura, and
H Hashimoto, and
T Ito, and
K Ogawa, and
T Satake
January 1986,
Journal of cardiovascular pharmacology,
Y Toki, and
N Hieda, and
K Okumura, and
H Hashimoto, and
T Ito, and
K Ogawa, and
T Satake
February 1991,
Japanese circulation journal,
Y Toki, and
N Hieda, and
K Okumura, and
H Hashimoto, and
T Ito, and
K Ogawa, and
T Satake
January 1991,
Pharmacotherapy,
Y Toki, and
N Hieda, and
K Okumura, and
H Hashimoto, and
T Ito, and
K Ogawa, and
T Satake
November 1996,
Nihon rinsho. Japanese journal of clinical medicine,
